Detalles de la búsqueda
1.
Increased Circulating Levels of CRP and IL-6 and Decreased Frequencies of T and B Lymphocyte Subsets Are Associated With Immune-Related Adverse Events During Combination Therapy With PD-1 Inhibitors for Liver Cancer.
Front Oncol
; 12: 906824, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35756643
2.
Correlation of HBV DNA and Hepatitis B Surface Antigen Levels With Tumor Response, Liver Function and Immunological Indicators in Liver Cancer Patients With HBV Infection Undergoing PD-1 Inhibition Combinational Therapy.
Front Immunol
; 13: 892618, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711409
3.
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trial.
Hepatol Int
; 15(6): 1402-1412, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850325
Resultados
1 -
3
de 3
1
Próxima >
>>